PRMEPrime Medicine, Inc.

$3.58-39% 1Y

Is it safe?

Watch

Caution warranted: heavy debt (CCC) and big price swings.

2 to watch, 4 without data
Credit gradeCCCderived · Jun 30, 2026

Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.

Drawdown risk100% volderived · Oct 8, 2026

Large price swings, high volatility. Worst drawdown -95% · now 44% below its 52-week high.

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can PRME take a bad year?

The deepest fall in PRME's price history on file is −95%; it is 45% below its high today.

−95%

Worst drawdown on file · −45% today

Cash runway
0.6 years

Cash runway · burning $39M a quarter at the current rate

Annualised volatility
100%

Annualised volatility · three times the market's own swing

Details›
Cash and short-term investments
$95M
EBITDA, trailing twelve months
−$189M
Operating profit, trailing twelve months
−$197M
Annualised volatilitytwo years of daily moves
100%
Worst drawdown on file
−95%
Below its 52-week high
45%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.